Relationship of Serum Zinc Level with Severity of Diabetic Nephropathy
NCT06690034 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 92
Last updated 2024-11-15
Summary
Zinc influences the production and action of erythropoietin (EPO), a hormone produced by the kidneys that stimulates red blood cell production.
However, further research is needed to fully understand the mechanisms and to develop evidence-based guidelines for zinc supplementation in patient with Diabetic kidney disease. this study aim to detect serum zinc level in patient with Diabetic kidney disease "CKD" and Study of association between serum zinc and serum urea, creatinine, GFR, hemoglobin ,HbA1c in DKD
Conditions
- Diabetic Nephropathy Type 2
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-01
- Primary Completion
- 2026-12-01
- Completion
- 2027-01-01
More Related Trials
-
The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD
NCT06398002 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Magnesium Supplementation in Diabetic Nephropathy
NCT03824379 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Vitamin D on Endothelial Function and Blood Biomarkers Including CD28 Null Cells in CKD
NCT02005718 ·Status: COMPLETED ·Phase: PHASE3
-
Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients
NCT02338934 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Long-term Serum Magnesium and Potassium Levels Optimization and Multifactorial Adherence Intervention on the Progression of Diabetic Kidney Disease.
NCT04942119 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Calcitriol on Biomarkers in Diabetic Kidney Disease Patients
NCT05298163 ·Status: UNKNOWN ·Phase: NA
-
Copper to Zinc Ratio in End Stage Renal Disease Patients Outcome
NCT07109778 ·Status: NOT_YET_RECRUITING
-
Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease
NCT03073369 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients
NCT01101217 ·Status: COMPLETED ·Phase: NA
-
A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation
NCT05549154 ·Status: UNKNOWN ·Phase: NA
-
A Research Study for Patients With End-Stage Renal Disease (ESRD)
NCT00110890 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease
NCT01988116 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy
NCT01673204 ·Status: UNKNOWN ·Phase: PHASE4
-
Ergocalciferol in Chronic Kidney Disease
NCT00411294 ·Status: COMPLETED
-
Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level
NCT01101113 ·Status: COMPLETED ·Phase: PHASE4
-
SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism
NCT00117052 ·Status: COMPLETED ·Phase: PHASE3
-
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
NCT00379899 ·Status: COMPLETED ·Phase: PHASE4
-
Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment
NCT04637360 ·Status: COMPLETED ·Phase: NA
-
A Study of SHR6508 in Secondary Hyperparathyroidism
NCT05663411 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients
NCT02999204 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 3 Study of KHK7580
NCT02549391 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients.
NCT00744302 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)
NCT00113945 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate
NCT01163162 ·Status: COMPLETED ·Phase: PHASE4
-
Vitamin D, Insulin Resistance and Inflammation in ESRD
NCT00656032 ·Status: COMPLETED ·Phase: PHASE2